Serotonin transporter availability in adults with autism—a positron emission tomography study

Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involveme...

Full description

Saved in:
Bibliographic Details
Published inMolecular psychiatry Vol. 26; no. 5; pp. 1647 - 1658
Main Authors Andersson, Max, Tangen, Ämma, Farde, Lars, Bölte, Sven, Halldin, Christer, Borg, Jacqueline, Lundberg, Johan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.05.2021
Nature Publishing Group
Subjects
59/78
631/378
692/699/476/1373
Adult
Autism
Autism Spectrum Disorder - diagnostic imaging
Autistic Disorder - diagnostic imaging
Behavioral Sciences
Biological Psychology
Brain - diagnostic imaging
Brain - metabolism
Brain stem
Carrier proteins
Cognitive ability
Health aspects
Humans
Hypotheses
Medicine
Medicine & Public Health
Neurodevelopment
Neurosciences
Pharmacotherapy
Phenotypes
Physiological aspects
Positron emission tomography
Psychiatry
Serotonin
Serotonin Plasma Membrane Transport Proteins - genetics
Serotonin Plasma Membrane Transport Proteins - metabolism
Serotonin transporter
Substantia grisea
Tomography
Sweden
Online AccessGet full text

Cover

Abstract Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involvement in the neurodevelopment of ASD is one of the longest standing. Reuptake through the 5-HT transporter (5-HTT) is the main pathway decreasing extracellular 5-HT in the brain and a marker for the 5-HT system, but in vivo investigations of the 5-HTT and the 5-HT system in ASD are scarce and so far inconclusive. To quantify possible alterations in the 5-HT system in ASD, we used positron emission tomography and the radioligand [ 11 C]MADAM to measure 5-HTT availability in the brain of 15 adults with ASD and 15 controls. Moreover, we examined correlations between regional 5-HTT availability and behavioral phenotype assessments regarding ASD core symptoms. In the ASD group, we found significantly lower 5-HTT availability in total gray matter, brainstem, and 9 of 18 examined subregions of gray matter. In addition, several correlations between regional 5-HTT availability and social cognitive test performance were found. The results confirm the hypothesis that 5-HTT availability is lower in the brain of adult individuals with ASD, and are consistent with the theory of 5-HT involvement in ASD neurodevelopment. The findings endorse the central role of 5-HT in the physiology of ASD, and confirm the need for a continued investigation of the 5-HT system in order to disentangle the biology of ASD.
AbstractList Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involvement in the neurodevelopment of ASD is one of the longest standing. Reuptake through the 5-HT transporter (5-HTT) is the main pathway decreasing extracellular 5-HT in the brain and a marker for the 5-HT system, but in vivo investigations of the 5-HTT and the 5-HT system in ASD are scarce and so far inconclusive. To quantify possible alterations in the 5-HT system in ASD, we used positron emission tomography and the radioligand [ 11 C]MADAM to measure 5-HTT availability in the brain of 15 adults with ASD and 15 controls. Moreover, we examined correlations between regional 5-HTT availability and behavioral phenotype assessments regarding ASD core symptoms. In the ASD group, we found significantly lower 5-HTT availability in total gray matter, brainstem, and 9 of 18 examined subregions of gray matter. In addition, several correlations between regional 5-HTT availability and social cognitive test performance were found. The results confirm the hypothesis that 5-HTT availability is lower in the brain of adult individuals with ASD, and are consistent with the theory of 5-HT involvement in ASD neurodevelopment. The findings endorse the central role of 5-HT in the physiology of ASD, and confirm the need for a continued investigation of the 5-HT system in order to disentangle the biology of ASD.
Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involvement in the neurodevelopment of ASD is one of the longest standing. Reuptake through the 5-HT transporter (5-HTT) is the main pathway decreasing extracellular 5-HT in the brain and a marker for the 5-HT system, but in vivo investigations of the 5-HTT and the 5-HT system in ASD are scarce and so far inconclusive. To quantify possible alterations in the 5-HT system in ASD, we used positron emission tomography and the radioligand [11C]MADAM to measure 5-HTT availability in the brain of 15 adults with ASD and 15 controls. Moreover, we examined correlations between regional 5-HTT availability and behavioral phenotype assessments regarding ASD core symptoms. In the ASD group, we found significantly lower 5-HTT availability in total gray matter, brainstem, and 9 of 18 examined subregions of gray matter. In addition, several correlations between regional 5-HTT availability and social cognitive test performance were found. The results confirm the hypothesis that 5-HTT availability is lower in the brain of adult individuals with ASD, and are consistent with the theory of 5-HT involvement in ASD neurodevelopment. The findings endorse the central role of 5-HT in the physiology of ASD, and confirm the need for a continued investigation of the 5-HT system in order to disentangle the biology of ASD.Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involvement in the neurodevelopment of ASD is one of the longest standing. Reuptake through the 5-HT transporter (5-HTT) is the main pathway decreasing extracellular 5-HT in the brain and a marker for the 5-HT system, but in vivo investigations of the 5-HTT and the 5-HT system in ASD are scarce and so far inconclusive. To quantify possible alterations in the 5-HT system in ASD, we used positron emission tomography and the radioligand [11C]MADAM to measure 5-HTT availability in the brain of 15 adults with ASD and 15 controls. Moreover, we examined correlations between regional 5-HTT availability and behavioral phenotype assessments regarding ASD core symptoms. In the ASD group, we found significantly lower 5-HTT availability in total gray matter, brainstem, and 9 of 18 examined subregions of gray matter. In addition, several correlations between regional 5-HTT availability and social cognitive test performance were found. The results confirm the hypothesis that 5-HTT availability is lower in the brain of adult individuals with ASD, and are consistent with the theory of 5-HT involvement in ASD neurodevelopment. The findings endorse the central role of 5-HT in the physiology of ASD, and confirm the need for a continued investigation of the 5-HT system in order to disentangle the biology of ASD.
Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involvement in the neurodevelopment of ASD is one of the longest standing. Reuptake through the 5-HT transporter (5-HTT) is the main pathway decreasing extracellular 5-HT in the brain and a marker for the 5-HT system, but in vivo investigations of the 5-HTT and the 5-HT system in ASD are scarce and so far inconclusive. To quantify possible alterations in the 5-HT system in ASD, we used positron emission tomography and the radioligand [.sup.11C]MADAM to measure 5-HTT availability in the brain of 15 adults with ASD and 15 controls. Moreover, we examined correlations between regional 5-HTT availability and behavioral phenotype assessments regarding ASD core symptoms. In the ASD group, we found significantly lower 5-HTT availability in total gray matter, brainstem, and 9 of 18 examined subregions of gray matter. In addition, several correlations between regional 5-HTT availability and social cognitive test performance were found. The results confirm the hypothesis that 5-HTT availability is lower in the brain of adult individuals with ASD, and are consistent with the theory of 5-HT involvement in ASD neurodevelopment. The findings endorse the central role of 5-HT in the physiology of ASD, and confirm the need for a continued investigation of the 5-HT system in order to disentangle the biology of ASD.
Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involvement in the neurodevelopment of ASD is one of the longest standing. Reuptake through the 5-HT transporter (5-HTT) is the main pathway decreasing extracellular 5-HT in the brain and a marker for the 5-HT system, but in vivo investigations of the 5-HTT and the 5-HT system in ASD are scarce and so far inconclusive. To quantify possible alterations in the 5-HT system in ASD, we used positron emission tomography and the radioligand [ C]MADAM to measure 5-HTT availability in the brain of 15 adults with ASD and 15 controls. Moreover, we examined correlations between regional 5-HTT availability and behavioral phenotype assessments regarding ASD core symptoms. In the ASD group, we found significantly lower 5-HTT availability in total gray matter, brainstem, and 9 of 18 examined subregions of gray matter. In addition, several correlations between regional 5-HTT availability and social cognitive test performance were found. The results confirm the hypothesis that 5-HTT availability is lower in the brain of adult individuals with ASD, and are consistent with the theory of 5-HT involvement in ASD neurodevelopment. The findings endorse the central role of 5-HT in the physiology of ASD, and confirm the need for a continued investigation of the 5-HT system in order to disentangle the biology of ASD.
Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism spectrum disorder (ASD). The biological underpinnings of ASD are not well known, but the hypothesis of serotonin (5-HT) involvement in the neurodevelopment of ASD is one of the longest standing. Reuptake through the 5-HT transporter (5-HTT) is the main pathway decreasing extracellular 5-HT in the brain and a marker for the 5-HT system, but in vivo investigations of the 5-HTT and the 5-HT system in ASD are scarce and so far inconclusive. To quantify possible alterations in the 5-HT system in ASD, we used positron emission tomography and the radioligand [11C]MADAM to measure 5-HTT availability in the brain of 15 adults with ASD and 15 controls. Moreover, we examined correlations between regional 5-HTT availability and behavioral phenotype assessments regarding ASD core symptoms. In the ASD group, we found significantly lower 5-HTT availability in total gray matter, brainstem, and 9 of 18 examined subregions of gray matter. In addition, several correlations between regional 5-HTT availability and social cognitive test performance were found. The results confirm the hypothesis that 5-HTT availability is lower in the brain of adult individuals with ASD, and are consistent with the theory of 5-HT involvement in ASD neurodevelopment. The findings endorse the central role of 5-HT in the physiology of ASD, and confirm the need for a continued investigation of the 5-HT system in order to disentangle the biology of ASD.
Audience Academic
Author Tangen, Ämma
Borg, Jacqueline
Andersson, Max
Halldin, Christer
Lundberg, Johan
Bölte, Sven
Farde, Lars
Author_xml – sequence: 1
  givenname: Max
  orcidid: 0000-0003-0024-6388
  surname: Andersson
  fullname: Andersson, Max
  email: max.andersson@ki.se
  organization: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Region Stockholm
– sequence: 2
  givenname: Ämma
  surname: Tangen
  fullname: Tangen, Ämma
  organization: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Region Stockholm
– sequence: 3
  givenname: Lars
  orcidid: 0000-0003-1297-0816
  surname: Farde
  fullname: Farde, Lars
  organization: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Region Stockholm
– sequence: 4
  givenname: Sven
  orcidid: 0000-0002-4579-4970
  surname: Bölte
  fullname: Bölte, Sven
  organization: Department of Women’s and Children’s Health, Karolinska Institutet, Center of Neurodevelopmental Disorders (KIND), Center for Psychiatry Research, Stockholm Health Care Services, Region Stockholm, Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Curtin Autism Research Group, School of Occupational Therapy, Social Work and Speech Pathology, Curtin University
– sequence: 5
  givenname: Christer
  surname: Halldin
  fullname: Halldin, Christer
  organization: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Region Stockholm
– sequence: 6
  givenname: Jacqueline
  surname: Borg
  fullname: Borg, Jacqueline
  organization: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Region Stockholm
– sequence: 7
  givenname: Johan
  orcidid: 0000-0002-4298-3936
  surname: Lundberg
  fullname: Lundberg, Johan
  organization: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Region Stockholm
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32848204$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:144502071$$DView record from Swedish Publication Index
BookMark eNp9Us1u1DAQjlAR_YEX4IAiceGSYsc_sS9IVUUBqRIH4Gx5vZNdl8RebKfV3ngInrBPwiy7LWyFKivyyN9PNDPfcXUQYoCqeknJKSVMvc2cMkUa0uJHlFQNe1IdUd7JRohOHWDNhG44VfywOs75ipANKJ5Vh6xVXLWEH1XmC6RYYvChLsmGvIqpQKrttfWDnfnBl3WNmJ1PQ8n1jS_L2k7F5_H25y9br2L2JcVQw-hz9liUOMZFsqvlus5lmq-fV097O2R4sbtPqm8X77-ef2wuP3_4dH522TjR6dJwriRjMNO9o9QC67ltVSdaJTQD57gDYqVmlrmZ0yBdr5TkGrTrtdAtIidVs_XNN7CaZmaV_GjT2kTrze7pO1ZguFSyo8h_t-UjMsLcQcD2hz3ZPhL80izitVFU6I51aPBmZ5DijwlyMTgCB8NgA8Qpm5azTnFKpUDq6wfUqzilgOMwrWCMCLKxvGct7ADGhz7if93G1JxJyTihVBBknf6HhWeOK3CYj97j-57g1b-N3nd4FwEkqC3BpZhzgt44X2zBZaKzHwwlZpM2s02bwbSZP2kzDKXtA-md-6MittsUksMC0t9pPKL6DYKP6Ws
CitedBy_id crossref_primary_10_3390_brainsci14070733
crossref_primary_10_53053_QZAQ6791
crossref_primary_10_1177_02698811221092509
crossref_primary_10_1016_j_conb_2024_102932
crossref_primary_10_3389_fnins_2022_806876
crossref_primary_10_1038_s41386_024_01859_6
crossref_primary_10_3389_fnins_2023_1087788
crossref_primary_10_3390_diagnostics12010165
crossref_primary_10_1038_s41380_024_02776_2
crossref_primary_10_2217_fmb_2023_0051
crossref_primary_10_1016_j_expneurol_2024_114695
crossref_primary_10_1038_s41380_021_01168_0
crossref_primary_10_1080_20473869_2024_2438771
crossref_primary_10_3390_jpm12060923
crossref_primary_10_1007_s00787_025_02661_5
crossref_primary_10_3390_nu13124497
crossref_primary_10_1007_s10803_021_05095_5
crossref_primary_10_2174_0929867330666230131115031
crossref_primary_10_1038_s41380_023_02060_9
crossref_primary_10_1016_j_neuropharm_2024_110057
crossref_primary_10_1134_S0006297923030021
crossref_primary_10_1186_s12974_023_02901_y
crossref_primary_10_4236_psych_2023_145044
crossref_primary_10_1016_j_brainresbull_2023_110862
crossref_primary_10_1007_s12264_022_00876_z
crossref_primary_10_1016_j_neuropharm_2023_109634
crossref_primary_10_1007_s00213_022_06228_z
crossref_primary_10_3389_fnint_2021_760116
crossref_primary_10_1515_revneuro_2023_0055
crossref_primary_10_3389_fendo_2024_1343759
crossref_primary_10_31857_S0320972523030028
crossref_primary_10_5964_bioling_9319
crossref_primary_10_1002_advs_202004393
Cites_doi 10.1016/S0140-6736(06)69041-7
10.1007/s10803-014-2336-y
10.1016/j.neulet.2006.06.004
10.1111/jcpp.12499
10.1016/j.neuropsychologia.2009.09.024
10.1016/j.neuroscience.2016.02.021
10.1016/j.neurobiolaging.2019.03.021
10.1002/syn.20189
10.1093/cercor/bhx272
10.1016/S1474-4422(15)00044-7
10.1523/JNEUROSCI.0659-17.2017
10.1111/1469-7610.00715
10.3389/fpsyt.2016.00188
10.1111/j.1651-2227.2010.01755.x
10.1002/ana.410080102
10.2466/pms.1988.67.1.3
10.1016/0304-3940(86)90327-7
10.1001/archpsyc.60.5.524
10.1016/j.neuroimage.2012.01.021
10.1016/j.pscychresns.2011.04.007
10.1176/appi.books.9780890425596
10.1186/s12916-017-0993-3
10.1126/science.1243091
10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9
10.1096/fj.13-246546
10.1038/s41586-018-0416-4
10.1086/383251
10.1016/S0028-3908(99)00010-6
10.1146/annurev-psych-010416-044046
10.1038/sj.npp.1301406
10.1016/S0022-3476(61)80261-8
10.1016/j.neuropharm.2018.12.024
10.1073/pnas.1112345109
10.1001/jama.2017.3413
10.1016/j.neuroimage.2006.01.021
10.1016/j.ijdevneu.2004.05.004
10.1016/j.neuroscience.2015.11.010
10.1002/aur.1317
10.1002/syn.20382
10.1126/scitranslmed.aam8434
10.1002/syn.20297
10.1007/BF02212938
10.1016/j.neuroscience.2016.02.037
10.1016/j.bbr.2014.05.022
10.1192/bjp.bp.113.143784
10.1006/nimg.2002.1152
10.1007/s10803-006-0107-0
10.1016/j.brainres.2007.10.063
10.1007/s00213-018-4872-1
10.1002/syn.20422
10.1006/nimg.1996.0066
10.1016/j.ijdevneu.2004.07.022
10.1016/j.ijdevneu.2004.08.002
10.1016/j.neuroimage.2007.10.016
10.1016/S0361-9230(01)00615-3
10.1038/npp.2016.166
10.1097/00004647-200204000-00013
10.1016/j.neuroscience.2011.10.005
10.1002/aur.1761
10.1097/00004583-200404000-00016
10.1523/JNEUROSCI.2534-15.2016
10.1016/j.euroneuro.2014.02.004
10.1016/j.mehy.2009.11.015
10.1111/j.1469-8749.2008.03027.x
10.1016/j.neuropharm.2011.02.002
10.1016/j.neures.2006.10.018
10.1038/nature12518
10.1176/jnp.2.3.268
10.1016/0014-2999(69)90113-7
10.1146/annurev.med.60.042307.110802
10.1023/A:1005608014889
10.1111/j.1469-7610.2004.00262.x
10.1001/archgenpsychiatry.2011.144
10.1111/jcpp.12329
10.1176/appi.neuropsych.11080202
10.1002/syn.20443
10.1111/j.2517-6161.1995.tb02031.x
10.1046/j.1365-2540.2001.00901.x
10.1111/jnc.14832
10.1001/archgenpsychiatry.2009.137
10.1002/14651858.CD004677.pub3
10.1176/ajp.2006.163.5.934
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2021 Nature Publishing Group
The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2021 Nature Publishing Group
– notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
ADTPV
AOWAS
D8T
ZZAVC
DOI 10.1038/s41380-020-00868-3
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef

MEDLINE

ProQuest One Psychology
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature Link
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-5578
EndPage 1658
ExternalDocumentID oai_swepub_ki_se_468671
PMC8159737
A663401150
32848204
10_1038_s41380_020_00868_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Sweden
GeographicLocations_xml – name: Sweden
GrantInformation_xml – fundername: European Autism Interventions – a Multicentre Study for Developing New Medications (EU-AIMS), EU-AIMS receives support from the Innovative Medicines Initiative Joint Undertaking (JU) under grant agreement no. 115300, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in kind contribution, and from Autism Speaks.) The Swedish Brain Foundation, the Stockholm Brain Institute and the Thuring Foundation.
– fundername: Vetenskapsrådet (Swedish Research Council)
  grantid: 2013-09304
  funderid: https://doi.org/10.13039/501100004359
– fundername: European Autism Interventions – a Multicentre Study for Developing New Medications (EU-AIMS), EU-AIMS receives support from the Innovative Medicines Initiative Joint Undertaking (JU) under grant agreement no. 115300, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in kind contribution, and from Autism Speaks. The Stockholm Brain Institute.
– fundername: ;
– fundername: ;
  grantid: 2013-09304
GroupedDBID ---
-Q-
0R~
123
29M
2WC
36B
39C
3V.
4.4
406
53G
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AXYYD
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F5P
FDQFY
FEDTE
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
IPY
ITC
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
NAO
NQJWS
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UKHRP
~8M
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
AEIIB
PMFND
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ADTPV
AOWAS
D8T
PUEGO
ZZAVC
ID FETCH-LOGICAL-c579t-448633eb9fc11ae3f4a287528593ecc4ce0a693a3cbc9e6cf88649e9cf9592693
IEDL.DBID C6C
ISSN 1359-4184
1476-5578
IngestDate Mon Aug 25 03:34:24 EDT 2025
Thu Aug 21 14:08:23 EDT 2025
Fri Jul 11 11:44:35 EDT 2025
Fri Jul 25 09:01:57 EDT 2025
Tue Jun 17 21:48:40 EDT 2025
Tue Jun 10 20:23:50 EDT 2025
Mon Jul 21 05:55:41 EDT 2025
Thu Apr 24 23:02:01 EDT 2025
Tue Jul 01 00:21:53 EDT 2025
Fri Feb 21 02:39:29 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c579t-448633eb9fc11ae3f4a287528593ecc4ce0a693a3cbc9e6cf88649e9cf9592693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4579-4970
0000-0003-1297-0816
0000-0003-0024-6388
0000-0002-4298-3936
OpenAccessLink https://www.nature.com/articles/s41380-020-00868-3
PMID 32848204
PQID 2533050597
PQPubID 44096
PageCount 12
ParticipantIDs swepub_primary_oai_swepub_ki_se_468671
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8159737
proquest_miscellaneous_2437841165
proquest_journals_2533050597
gale_infotracmisc_A663401150
gale_infotracacademiconefile_A663401150
pubmed_primary_32848204
crossref_citationtrail_10_1038_s41380_020_00868_3
crossref_primary_10_1038_s41380_020_00868_3
springer_journals_10_1038_s41380_020_00868_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-05-01
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Molecular psychiatry
PublicationTitleAbbrev Mol Psychiatry
PublicationTitleAlternate Mol Psychiatry
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References DelisDKramerJBaldoJKaplanEShimamuraAVerbal and design fluency in patients with frontal lobe lesionsJ Int Neuropsychol Soc.2002758696
AbramsonRKWrightHHCarpenterRBrennanWLumpuyOColeEElevated blood serotonin in autistic probands and their first-degree relativesJ Autism Dev Disord.1989193974071:STN:280:DyaK3c%2FgvVKqtQ%3D%3D2793785
LundströmSChangZRåstamMGillbergCLarssonHAnckarsäterHAutism spectrum disorders and autisticlike traitsArch Gen Psychiatry.201269465222213788
CrossSKimSJWeissLADelahantyRJSutcliffeJSLeventhalBLMolecular genetics of the platelet serotonin system in first-degree relatives of patients with autismNeuropsychopharmacology.200833353601:CAS:528:DC%2BD2sXhsVSktrrN17406648
BeversdorfDQNordgrenREBonabAAPhDWeiseSBDoughertyDD5-ht2 receptor distribution shown by [18F]Setoperone PET in high-functioning autistic adultsJ Neuropsychiatry Clin Neurosci.20122419171:CAS:528:DC%2BC38Xht1ens7zJ22772667
LundquistPRomanMSyväanenSHartvigPBlomquistGHammarlund-UdenaesMEffect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and ratsSynapse.20076144091:CAS:528:DC%2BD2sXktlKqu7k%3D17372973
JovanovicHLundbergJKarlssonPCerinÅSaijoTVarroneASex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PETNeuroimage.20083914081918036835
HorderJAnderssonMMendezMASinghNTangenÄLundbergJGABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse modelsSci Transl Med201810eaam843430282698
BölteSCiaramidaroASchlittSHainzDKliemannDPoustkaFTraining-induced plasticity of the social brain in autism spectrum disorderBr J Psychiatry.20152071495725792694
TartaglioneAMSchiaviSCalamandreiGTrezzaVPrenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorderNeuropharmacology20191591074771:CAS:528:DC%2BC1MXhvFSlsro%3D30639388
HardeboJEOwmanCBarrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interfaceAnn Neurol.198081111:CAS:528:DyaL3cXlt12itb4%3D6105837
HoughLHSegalSEffects of developmental hyperserotonemia on the morphology of rat dentate nuclear neuronsNeuroscience.2016322178941:CAS:528:DC%2BC28XivVKjurk%3D26892293
GabrieleSSaccoRPersicoAMBlood serotonin levels in autism spectrum disorder: a systematic review and meta-analysisEur Neuropsychopharmacol.201424919291:CAS:528:DC%2BC2cXjsF2jsr0%3D24613076
HalldinCLundbergJSóvágóJGulyásBGuilloteauDVercouillieJ[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PETSynapse.200558173831:CAS:528:DC%2BD2MXhtFensrbO16138320
BonninALevittPFetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brainNeuroscience.2011197171:CAS:528:DC%2BC3MXhsVartLbF220016833225275
HeyesCMFrithCDThe cultural evolution of mind readingScience20143441357631:CAS:528:DC%2BC2cXpslygsbs%3D
DesikanRSSeFFischlBQuinnBTDickersonBCBlackerDAn automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interestNeuroimage.2006319688016530430
Whitaker-AzmitiaPMBehavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?Int J Dev Neurosci.20052375831:CAS:528:DC%2BD2MXhslCgtrc%3D15730889
PatrickRPAmesBNVitamin D hormone regulates serotonin synthesis. Part 1: relevance for autismFASEB J.20142823984131:CAS:528:DC%2BC2cXhtVSnsr3N24558199
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
Stockholms Läns Landsting [Stockholm County Council]. Regionalt vårdprogram ADHD, lindrig utvecklingsstörning och autismspektrumtillstånd hos barn, ungdomar och vuxna [Regional Service Program—ADHD, intellectual disabilities and autism spectrum disorders in children, adolescents and adults]. Stockholm, Sweden: Stockholms Läns Landsting; 2010.
HadjikhaniNSerotonin, pregnancy and increased autism prevalence: is there a link?Med Hypotheses.20107488031:CAS:528:DC%2BC3cXktlCktLg%3D20018455
OblakAGibbsTTBlattGJReduced serotonin receptor subtypes in a limbic and a neocortical region in autismAutism Res.201365718323894004
DziobekIFleckSKalbeERogersKHassenstabJBrandMIntroducing MASC: a movie for the assessment of social cognitionJ Autism Dev Disord.2006366233616755332
Veenstra-VanderWeeleJMullerCLIwamotoHSauerJEOwensWAShahCRAutism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behaviorProc Natl Acad Sci USA.20121095469741:CAS:528:DC%2BC38XlslOjsbY%3D22431635
CookEHLeventhalBLHellerWMetzJWainwrightMFreedmanDXAutistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligenceJ Neuropsychiatry Clin Neurosci.19902268742136085
KarrerTMMcLaughlinCLGuaglianoneCPSamanez-LarkinGRReduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studiesNeurobiol Aging.2019801101:CAS:528:DC%2BC1MXnvFGltb4%3D310551626679764
KepserLJHombergJRThe neurodevelopmental effects of serotonin: a behavioural perspectiveBehav Brain Res.20152773131:CAS:528:DC%2BC2cXhsVymsbfP24859172
LundströmSReichenbergAMelkeJRåstamMKerekesNLichtensteinPAutism spectrum disorders and coexisting disorders in a nationwide Swedish twin studyJ Child Psychol Psychiatry Allied Discip.20155670210
CheverudJMA simple correction for multiple comparisons in interval mapping genome scansHeredity.2001875281:CAS:528:DC%2BD3MXotVWns7w%3D11678987
AlmeidaRADickinsonJEMayberyMTBadcockJCBadcockDRA new step towards understanding embedded figures test performance in the autism spectrum: the radial frequency search taskNeuropsychologia.2010483748119786040
SujanACRickertMEÖbergASQuinnPDHernández-DíazSAlmqvistCAssociations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspringJAMA.2017317155362284184795875187
BrummelteSMc GlanaghyEBonninAOberlanderTFDevelopmental changes in serotonin signaling: implications for early brain function, behavior and adaptationNeuroscience.2017342212311:CAS:528:DC%2BC28XjtFOntrk%3D26905950
OnishiKHBaillargeonRDo 15-month-old infants understand false beliefs?Science.20122552559
BarnesNMSharpTA review of central 5-HT receptors and their functionNeuropharmacology.19993810831521:CAS:528:DyaK1MXltVCgsrg%3D10462127
AzmitiaECSinghJSWhitaker-AzmitiaPMIncreased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donorsNeuropharmacology.2011601347541:CAS:528:DC%2BC3MXkvVKiu7g%3D21329710
MullerCLAnackerAMRogersTDGoedenNKellerEHForsbergCGImpact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and neurodevelopmentNeuropsychopharmacology.201742427361:CAS:528:DC%2BC28XhsV2qu7%2FL27550733
MiyazakiKNaritaNNaritaMMaternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autismInt J Dev Neurosci.200523287971:CAS:528:DC%2BD2MXhvF2ntL8%3D15749253
ConstantinoJNToddRDAutistic traits in the general population: a twin studyArch Gen Psychiatry.2003605243012742874
FernellEBarnevik-OlssonMBagenholmGGillbergCGustafssonSSääfMSerum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autismActa Paediatr Int J Paediatr.20109974371:CAS:528:DC%2BC3cXmtlGgsb8%3D
HospitalKNaritaNKatoMTazoeMMiyazakiKNaritaMIncreased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autismPediatr Res.2002525769
LefevreAMottoleseRRedoutéJCostesNLe BarsDGeoffrayMMOxytocin fails to recruit serotonergic neurotransmission in the autistic brainCereb Cortex.20182841697829045584
UebelhackRFrankeLHeroldNPlotkinMAmthauerHFelixRBrain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in plateletsNeurosci Lett.200640615381:CAS:528:DC%2BD28XpsVOnu7w%3D16934400
DalyEMDeeleyQEckerCCraigMHallahanBMurphyCSerotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletionArch Gen Psychiatry.20126910031322638012
BergerMGrayJARothBLThe expanded biology of serotoninAnnu Rev Med.200960355661:CAS:528:DC%2BD1MXitlyntb8%3D196305765864293
DölenGDarvishzadehAHuangKWMalenkaRCSocial reward requires coordinated activity of nucleus accumbens oxytocin and serotoninNature.201350117984240258384091761
SzaboZMcCannUDWilsonAAScheffelUOwonikokoTMathewsWBComparison of (+)-\chm{^{11}}C-McN5652 and \chm{^{11}}C-DASB as serotonin transporter radioligands under various experimental conditionsJ Nucl Med.200243678921:CAS:528:DC%2BD38XktlOlurw%3D119945342078607
MakkonenIRiikonenRKokkiHAiraksinenMMKuikkaJTSerotonin and dopamine transporter binding in children with autism determined by SPECTDev Med Child Neurol.200850593718754896
Baron-CohenSWheelwrightSHillJRasteYPlumbIThe ‘Reading the Mind in the Eyes’ Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autismJ Child Psychol Psychiatry.200142241511:STN:280:DC%2BD3M7ovVOgtg%3D%3D11280420
MulderEJAndersonGMKemaIPDe BildtAVan LangNDJDen BoerJAPlatelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlatesJ Am Acad Child Adolesc Psychiatry.200443491915187810
LundbergJHalldinCFardeLMeasurement of serotonin transporter binding with PET and [11 C] MADAM: a test–retest reproducibility studySynapse.200626325663
BenjaminiYHochbergYControlling the false discovery rate: a practical and powerful approach to multiple testingJ R Stat Soc Ser B.199557289300
LefevreARichardNJazayer
S Yamamoto (868_CR61) 2007; 61
RR Girgis (868_CR29) 2011; 194
JG Snodgrass (868_CR47) 1988; 67
JJ Walsh (868_CR68) 2018; 560
N Goeden (868_CR80) 2016; 36
PM Whitaker-Azmitia (868_CR21) 2001; 56
A Lefevre (868_CR31) 2018; 28
I Dziobek (868_CR43) 2006; 36
868_CR38
EC Azmitia (868_CR23) 2011; 60
H Jovanovic (868_CR39) 2008; 39
S Baron-Cohen (868_CR42) 2001; 42
C Halldin (868_CR48) 2005; 58
S Lundström (868_CR3) 2012; 69
LJ Kepser (868_CR59) 2015; 277
AC Sujan (868_CR86) 2017; 317
B Tick (868_CR4) 2016; 57
G Dölen (868_CR69) 2013; 501
I Makkonen (868_CR32) 2008; 50
S Bölte (868_CR67) 2015; 207
868_CR1
J Veenstra-VanderWeele (868_CR17) 2012; 109
A Carlsson (868_CR16) 1969; 5
E Fernell (868_CR78) 2010; 99
DC Chugani (868_CR26) 1999; 45
S Lundström (868_CR10) 2015; 56
A Lefevre (868_CR71) 2017; 37
CL Muller (868_CR19) 2016; 321
AA Lammertsma (868_CR51) 1996; 4
M Tiger (868_CR88) 2018; 235
C Brandenburg (868_CR25) 2019; 151
DR Morales (868_CR85) 2018; 16
A Oblak (868_CR24) 2013; 6
N Hadjikhani (868_CR55) 2010; 74
Y Ikoma (868_CR36) 2002; 22
U Frith (868_CR66) 2004; 45
T Hirosawa (868_CR70) 2017; 10
TM Karrer (868_CR40) 2019; 80
Y Benjamini (868_CR52) 1995; 57
F Happé (868_CR64) 2017; 68
DH Geschwind (868_CR8) 2015; 14
CL Muller (868_CR77) 2017; 42
IM McNamara (868_CR57) 2008; 1189
KH Onishi (868_CR63) 2012; 255
RP Patrick (868_CR79) 2014; 28
DR Nyholt (868_CR54) 2004; 74
JN Constantino (868_CR2) 2003; 60
CM Heyes (868_CR65) 2014; 344
RA Almeida (868_CR46) 2010; 48
R Uebelhack (868_CR18) 2006; 406
RK Abramson (868_CR73) 1989; 19
E Loth (868_CR9) 2016; 7
K Nakamura (868_CR33) 2010; 67
A Bonnin (868_CR20) 2011; 197
PM Whitaker-Azmitia (868_CR22) 2005; 23
B Fischl (868_CR49) 2012; 62
G Baird (868_CR5) 2006; 368
K Miyazaki (868_CR83) 2005; 23
M Berger (868_CR15) 2009; 60
J Lundberg (868_CR37) 2006; 263
P Lundquist (868_CR60) 2007; 61
EH Cook (868_CR75) 1990; 2
JM Cheverud (868_CR53) 2001; 87
G Xu (868_CR7) 2018; 28
LH Hough (868_CR58) 2016; 322
B Elfving (868_CR35) 2007; 61
S Baron-Cohen (868_CR44) 2000; 30
EJ Mulder (868_CR13) 2004; 43
Z Cselényi (868_CR89) 2002; 60
NM Barnes (868_CR14) 1999; 38
S Brummelte (868_CR56) 2017; 342
868_CR87
DGM Murphy (868_CR28) 2006; 163
K Hospital (868_CR84) 2002; 52
JE Hardebo (868_CR76) 1980; 8
EM Daly (868_CR72) 2012; 69
RJ Schain (868_CR11) 1961; 58
S Gabriele (868_CR12) 2014; 24
RS Desikan (868_CR50) 2006; 31
S Idring (868_CR6) 2015; 45
J Horder (868_CR41) 2018; 10
D Delis (868_CR45) 2002; 7
AM Tartaglione (868_CR81) 2019; 159
N Tsujino (868_CR82) 2007; 57
PM Whitaker-Azmitia (868_CR62) 1986; 67
SR Chandana (868_CR27) 2005; 23
Z Szabo (868_CR34) 2002; 43
DQ Beversdorf (868_CR30) 2012; 24
S Cross (868_CR74) 2008; 33
References_xml – reference: YamamotoSOnoeHTsukadaHWatanabeYEffects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brainSynapse.200761724311:CAS:528:DC%2BD2sXosVOis7g%3D17559093
– reference: IdringSLundbergMSturmHDalmanCGumpertCRaiDChanges in prevalence of autism spectrum disorders in 2001–2011: findings from the Stockholm Youth CohortJ Autism Dev Disord.20154517667325475364
– reference: HeyesCMFrithCDThe cultural evolution of mind readingScience20143441357631:CAS:528:DC%2BC2cXpslygsbs%3D
– reference: CookEHLeventhalBLHellerWMetzJWainwrightMFreedmanDXAutistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligenceJ Neuropsychiatry Clin Neurosci.19902268742136085
– reference: CheverudJMA simple correction for multiple comparisons in interval mapping genome scansHeredity.2001875281:CAS:528:DC%2BD3MXotVWns7w%3D11678987
– reference: ChuganiDCMuzikOBehenMRothermelRJanisseJJLeeJDevelopmental changes in brain serotonin synthesis capacity in autistic and nonautistic childrenAnn Neurol.199945287951:STN:280:DyaK1M7ntVamug%3D%3D10072042
– reference: Stockholms Läns Landsting [Stockholm County Council]. Regionalt vårdprogram ADHD, lindrig utvecklingsstörning och autismspektrumtillstånd hos barn, ungdomar och vuxna [Regional Service Program—ADHD, intellectual disabilities and autism spectrum disorders in children, adolescents and adults]. Stockholm, Sweden: Stockholms Läns Landsting; 2010.
– reference: MiyazakiKNaritaNNaritaMMaternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autismInt J Dev Neurosci.200523287971:CAS:528:DC%2BD2MXhvF2ntL8%3D15749253
– reference: HadjikhaniNSerotonin, pregnancy and increased autism prevalence: is there a link?Med Hypotheses.20107488031:CAS:528:DC%2BC3cXktlCktLg%3D20018455
– reference: Whitaker-AzmitiaPMAzmitiaECAutoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptorsNeurosci Lett.198667307121:CAS:528:DyaL28XksFGju74%3D3461314
– reference: DelisDKramerJBaldoJKaplanEShimamuraAVerbal and design fluency in patients with frontal lobe lesionsJ Int Neuropsychol Soc.2002758696
– reference: LundquistPRomanMSyväanenSHartvigPBlomquistGHammarlund-UdenaesMEffect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and ratsSynapse.20076144091:CAS:528:DC%2BD2sXktlKqu7k%3D17372973
– reference: LefevreAMottoleseRRedoutéJCostesNLe BarsDGeoffrayMMOxytocin fails to recruit serotonergic neurotransmission in the autistic brainCereb Cortex.20182841697829045584
– reference: BrandenburgCBlattGJDifferential serotonin transporter (5-HTT) and 5-HT2 receptor density in limbic and neocortical areas of adults and children with autism spectrum disorders: implications for selective serotonin reuptake inhibitor efficacyJ Neurochem.2019151642551:CAS:528:DC%2BC1MXitVejsL7I313251796900089
– reference: HalldinCLundbergJSóvágóJGulyásBGuilloteauDVercouillieJ[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PETSynapse.200558173831:CAS:528:DC%2BD2MXhtFensrbO16138320
– reference: MulderEJAndersonGMKemaIPDe BildtAVan LangNDJDen BoerJAPlatelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlatesJ Am Acad Child Adolesc Psychiatry.200443491915187810
– reference: DölenGDarvishzadehAHuangKWMalenkaRCSocial reward requires coordinated activity of nucleus accumbens oxytocin and serotoninNature.201350117984240258384091761
– reference: PatrickRPAmesBNVitamin D hormone regulates serotonin synthesis. Part 1: relevance for autismFASEB J.20142823984131:CAS:528:DC%2BC2cXhtVSnsr3N24558199
– reference: WalshJJChristoffelDJHeifetsBDBen-DorGASelimbeyogluAHungLW5-HT release in nucleus accumbens rescues social deficits in mouse autism modelNature.2018560589941:CAS:528:DC%2BC1cXhsVynsr3J300899108164568
– reference: BenjaminiYHochbergYControlling the false discovery rate: a practical and powerful approach to multiple testingJ R Stat Soc Ser B.199557289300
– reference: MullerCLAnackerAMJVeenstra-VanderWeeleJThe serotonin system in autism spectrum disorder: from biomarker to animal modelsNeuroscience.201632124411:CAS:528:DC%2BC2MXhvVChsbzI26577932
– reference: CrossSKimSJWeissLADelahantyRJSutcliffeJSLeventhalBLMolecular genetics of the platelet serotonin system in first-degree relatives of patients with autismNeuropsychopharmacology.200833353601:CAS:528:DC%2BD2sXhsVSktrrN17406648
– reference: OblakAGibbsTTBlattGJReduced serotonin receptor subtypes in a limbic and a neocortical region in autismAutism Res.201365718323894004
– reference: IkomaYSuharaTToyamaHIchimiyaTTakanoASudoYQuantitative analysis for estimating binding potential of the brain serotonin transporter with [11C]McN5652J Cereb Blood Flow Metab.2002224905011:CAS:528:DC%2BD38Xjt1Ogtr4%3D11919520
– reference: Baron-CohenSWheelwrightSHillJRasteYPlumbIThe ‘Reading the Mind in the Eyes’ Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autismJ Child Psychol Psychiatry.200142241511:STN:280:DC%2BD3M7ovVOgtg%3D%3D11280420
– reference: CarlssonACorrodiHFuxeKHökfeltTEffect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramineEur J Pharmacol19695357661:CAS:528:DyaF1MXkt1SktLk%3D5786359
– reference: TickBBoltonPHappéFRutterMRijsdijkFHeritability of autism spectrum disorders: a meta-analysis of twin studiesJ Child Psychol Psychiatry Allied Discip.20165758595
– reference: BeversdorfDQNordgrenREBonabAAPhDWeiseSBDoughertyDD5-ht2 receptor distribution shown by [18F]Setoperone PET in high-functioning autistic adultsJ Neuropsychiatry Clin Neurosci.20122419171:CAS:528:DC%2BC38Xht1ens7zJ22772667
– reference: ConstantinoJNToddRDAutistic traits in the general population: a twin studyArch Gen Psychiatry.2003605243012742874
– reference: FernellEBarnevik-OlssonMBagenholmGGillbergCGustafssonSSääfMSerum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autismActa Paediatr Int J Paediatr.20109974371:CAS:528:DC%2BC3cXmtlGgsb8%3D
– reference: BairdGSimonoffEPicklesAChandlerSLoucasTMeldrumDPrevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)Lancet.2006368210516844490
– reference: SnodgrassJGCorwinJPerceptual identification thresholds for 150 fragmented pictures from the Snodgrass and Vanderwart picture setPercept Mot Skills.1988673361:STN:280:DyaL1M%2FpvVaitw%3D%3D3211683
– reference: KarrerTMMcLaughlinCLGuaglianoneCPSamanez-LarkinGRReduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studiesNeurobiol Aging.2019801101:CAS:528:DC%2BC1MXnvFGltb4%3D310551626679764
– reference: MullerCLAnackerAMRogersTDGoedenNKellerEHForsbergCGImpact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and neurodevelopmentNeuropsychopharmacology.201742427361:CAS:528:DC%2BC28XhsV2qu7%2FL27550733
– reference: Veenstra-VanderWeeleJMullerCLIwamotoHSauerJEOwensWAShahCRAutism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behaviorProc Natl Acad Sci USA.20121095469741:CAS:528:DC%2BC38XlslOjsbY%3D22431635
– reference: AlmeidaRADickinsonJEMayberyMTBadcockJCBadcockDRA new step towards understanding embedded figures test performance in the autism spectrum: the radial frequency search taskNeuropsychologia.2010483748119786040
– reference: UebelhackRFrankeLHeroldNPlotkinMAmthauerHFelixRBrain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in plateletsNeurosci Lett.200640615381:CAS:528:DC%2BD28XpsVOnu7w%3D16934400
– reference: KepserLJHombergJRThe neurodevelopmental effects of serotonin: a behavioural perspectiveBehav Brain Res.20152773131:CAS:528:DC%2BC2cXhsVymsbfP24859172
– reference: LothEMurphyDGSpoorenWDefining precision medicine approaches to autism spectrum disorders: concepts and challengesFront Psychiatry.2016718
– reference: ChandanaSRBehenMEJuhászCMuzikORothermelRDMangnerTJSignificance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autismInt J Dev Neurosci.200523171821:CAS:528:DC%2BD2MXhvF2nt7s%3D15749243
– reference: LundströmSChangZRåstamMGillbergCLarssonHAnckarsäterHAutism spectrum disorders and autisticlike traitsArch Gen Psychiatry.201269465222213788
– reference: LundbergJHalldinCFardeLMeasurement of serotonin transporter binding with PET and [11 C] MADAM: a test–retest reproducibility studySynapse.200626325663
– reference: GeschwindDHStateMWGene hunting in autism spectrum disorder: on the path to precision medicineLancet Neurol.201514110920258910094694565
– reference: AzmitiaECSinghJSWhitaker-AzmitiaPMIncreased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donorsNeuropharmacology.2011601347541:CAS:528:DC%2BC3MXkvVKiu7g%3D21329710
– reference: LammertsmaAAHumeSPSimplified reference tissue model for PET receptor studiesNeuroimage.1996415381:STN:280:DyaK1c%2FgsFeltw%3D%3D9345505
– reference: DalyEMDeeleyQEckerCCraigMHallahanBMurphyCSerotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletionArch Gen Psychiatry.20126910031322638012
– reference: HappéFBirdGThe structure of social cognition: in(ter)dependence of sociocognitive processesAnnu Rev Psychol.2017682436727687121
– reference: CselényiZOlssonHFardeLGulyásBWavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11 C] FLB 457Neuroimage.2002604760
– reference: BarnesNMSharpTA review of central 5-HT receptors and their functionNeuropharmacology.19993810831521:CAS:528:DyaK1MXltVCgsrg%3D10462127
– reference: MakkonenIRiikonenRKokkiHAiraksinenMMKuikkaJTSerotonin and dopamine transporter binding in children with autism determined by SPECTDev Med Child Neurol.200850593718754896
– reference: SchainRJFreedmanDXStudies on 5-hydroxyindole metabolism in autistic and other mentally retarded childrenJ Pediatr.196158315201:STN:280:DyaF3c%2Fms12nsA%3D%3D13747230
– reference: AbramsonRKWrightHHCarpenterRBrennanWLumpuyOColeEElevated blood serotonin in autistic probands and their first-degree relativesJ Autism Dev Disord.1989193974071:STN:280:DyaK3c%2FgvVKqtQ%3D%3D2793785
– reference: McNamaraIMBorellaAWBialowasLAWhitaker-AzmitiaPMFurther studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changesBrain Res.20081189203141:CAS:528:DC%2BD1cXlt1Cjtw%3D%3D18062943
– reference: ElfvingBMadsenJMKnudsenGNeuroimaging of the serotonin reuptake site requires high-affinity ligandsSynapse.20076188281:CAS:528:DC%2BD2sXhtFaiu7fO17657807
– reference: NyholtDRA simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each otherAm J Hum Genet.20047476591:CAS:528:DC%2BD2cXivFCntL0%3D149974201181954
– reference: NakamuraKSekineYOuchiYTsujiiMYoshikawaEFutatsubashiMBrain serotonin and dopamine transporter bindings in adults with high-functioning autismArch Gen Psychiatry.20106759681:CAS:528:DC%2BC3cXhtlaqsrY%3D20048223
– reference: JovanovicHLundbergJKarlssonPCerinÅSaijoTVarroneASex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PETNeuroimage.20083914081918036835
– reference: TartaglioneAMSchiaviSCalamandreiGTrezzaVPrenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorderNeuropharmacology20191591074771:CAS:528:DC%2BC1MXhvFSlsro%3D30639388
– reference: GirgisRRSlifsteinMXuXFrankleWGAnagnostouEWassermanSThe 5-HT(2A) receptor and serotonin transporter in Asperger’s disorder: a PET study with [11C]MDL 100907 and [11C]DASBPsychiatry Res.201119423041:CAS:528:DC%2BC3MXhsFGqtbjE220790573225493
– reference: LefevreARichardNJazayeriMBeuriatP-AFieuxSZimmerLOxytocin and serotonin brain mechanisms in the nonhuman primateJ Neurosci.2017376741501:CAS:528:DC%2BC2sXhvFCht73N286071706596550
– reference: HardeboJEOwmanCBarrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interfaceAnn Neurol.198081111:CAS:528:DyaL3cXlt12itb4%3D6105837
– reference: TsujinoNNakataniYSekiYNakasatoANakamuraMSugawaraMAbnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autismNeurosci Res.200757289951:CAS:528:DC%2BD2sXhtlCmsL4%3D17157402
– reference: FrithUEmanuel Miller lecture: confusions and controversies about Asperger syndromeJ Child Psychol Psychiatry Allied Discip.20044567286
– reference: GabrieleSSaccoRPersicoAMBlood serotonin levels in autism spectrum disorder: a systematic review and meta-analysisEur Neuropsychopharmacol.201424919291:CAS:528:DC%2BC2cXjsF2jsr0%3D24613076
– reference: GoedenNVelasquezJArnoldKAChanYLundBTAndersonGMMaternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brainJ Neurosci.201636604191:CAS:528:DC%2BC28XhsF2ltr7I272516254887568
– reference: Williams K, Brignell A, Randall M, Silove N, Hazell P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2013. https://doi.org/10.1002/14651858.CD004677.pub3.
– reference: BonninALevittPFetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brainNeuroscience.2011197171:CAS:528:DC%2BC3MXhsVartLbF220016833225275
– reference: SzaboZMcCannUDWilsonAAScheffelUOwonikokoTMathewsWBComparison of (+)-\chm{^{11}}C-McN5652 and \chm{^{11}}C-DASB as serotonin transporter radioligands under various experimental conditionsJ Nucl Med.200243678921:CAS:528:DC%2BD38XktlOlurw%3D119945342078607
– reference: DesikanRSSeFFischlBQuinnBTDickersonBCBlackerDAn automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interestNeuroimage.2006319688016530430
– reference: HirosawaTKikuchiMOuchiYTakahashiTYoshimuraYKosakaHA pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorderAutism Res.201710821828266806
– reference: HoughLHSegalSEffects of developmental hyperserotonemia on the morphology of rat dentate nuclear neuronsNeuroscience.2016322178941:CAS:528:DC%2BC28XivVKjurk%3D26892293
– reference: BergerMGrayJARothBLThe expanded biology of serotoninAnnu Rev Med.200960355661:CAS:528:DC%2BD1MXitlyntb8%3D196305765864293
– reference: XuGStrathearnLLiuBBaoWCorrected prevalence of autism spectrum disorder among US children and adolescentsJAMA.201828201
– reference: LundströmSReichenbergAMelkeJRåstamMKerekesNLichtensteinPAutism spectrum disorders and coexisting disorders in a nationwide Swedish twin studyJ Child Psychol Psychiatry Allied Discip.20155670210
– reference: BölteSCiaramidaroASchlittSHainzDKliemannDPoustkaFTraining-induced plasticity of the social brain in autism spectrum disorderBr J Psychiatry.20152071495725792694
– reference: HorderJAnderssonMMendezMASinghNTangenÄLundbergJGABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse modelsSci Transl Med201810eaam843430282698
– reference: American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
– reference: OnishiKHBaillargeonRDo 15-month-old infants understand false beliefs?Science.20122552559
– reference: HospitalKNaritaNKatoMTazoeMMiyazakiKNaritaMIncreased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autismPediatr Res.2002525769
– reference: Baron-CohenSO’RiordanMStoneVJonesRPlaistedKRecognition of faux pas by normally developing children and children with Asperger syndrome or high-functioning autismJ Autism Dev Disord.2000306223
– reference: Whitaker-AzmitiaPMBehavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?Int J Dev Neurosci.20052375831:CAS:528:DC%2BD2MXhslCgtrc%3D15730889
– reference: BrummelteSMc GlanaghyEBonninAOberlanderTFDevelopmental changes in serotonin signaling: implications for early brain function, behavior and adaptationNeuroscience.2017342212311:CAS:528:DC%2BC28XjtFOntrk%3D26905950
– reference: MoralesDRSlatteryJEvansSKurzXAntidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerationsBMC Med.201816293326055767968
– reference: DziobekIFleckSKalbeERogersKHassenstabJBrandMIntroducing MASC: a movie for the assessment of social cognitionJ Autism Dev Disord.2006366233616755332
– reference: SujanACRickertMEÖbergASQuinnPDHernández-DíazSAlmqvistCAssociations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspringJAMA.2017317155362284184795875187
– reference: Whitaker-AzmitiaPMSerotonin and brain development: role in human developmental diseasesBrain Res Bull.200156479851:CAS:528:DC%2BD3MXptFylt7k%3D11750793
– reference: TigerMVarnäsKOkuboYLundbergJThe 5-HT 1B receptor—a potential target for antidepressant treatmentPsychopharmacology.20182351317341:CAS:528:DC%2BC1cXkslagtL8%3D295465515919989
– reference: MurphyDGMDalyESchmitzNToalFMurphyKCurranSCortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger’s syndrome: an in vivo SPECT studyAm J Psychiatry.2006163934616648340
– reference: FischlBFreeSurferNeuroimage.20126277481222485733685476
– volume: 368
  start-page: 210
  year: 2006
  ident: 868_CR5
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(06)69041-7
– volume: 45
  start-page: 1766
  year: 2015
  ident: 868_CR6
  publication-title: J Autism Dev Disord.
  doi: 10.1007/s10803-014-2336-y
– volume: 406
  start-page: 153
  year: 2006
  ident: 868_CR18
  publication-title: Neurosci Lett.
  doi: 10.1016/j.neulet.2006.06.004
– volume: 57
  start-page: 585
  year: 2016
  ident: 868_CR4
  publication-title: J Child Psychol Psychiatry Allied Discip.
  doi: 10.1111/jcpp.12499
– volume: 48
  start-page: 374
  year: 2010
  ident: 868_CR46
  publication-title: Neuropsychologia.
  doi: 10.1016/j.neuropsychologia.2009.09.024
– volume: 322
  start-page: 178
  year: 2016
  ident: 868_CR58
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2016.02.021
– volume: 80
  start-page: 1
  year: 2019
  ident: 868_CR40
  publication-title: Neurobiol Aging.
  doi: 10.1016/j.neurobiolaging.2019.03.021
– volume: 58
  start-page: 173
  year: 2005
  ident: 868_CR48
  publication-title: Synapse.
  doi: 10.1002/syn.20189
– volume: 52
  start-page: 576
  year: 2002
  ident: 868_CR84
  publication-title: Pediatr Res.
– volume: 28
  start-page: 4169
  year: 2018
  ident: 868_CR31
  publication-title: Cereb Cortex.
  doi: 10.1093/cercor/bhx272
– volume: 14
  start-page: 1109
  year: 2015
  ident: 868_CR8
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(15)00044-7
– volume: 37
  start-page: 6741
  year: 2017
  ident: 868_CR71
  publication-title: J Neurosci.
  doi: 10.1523/JNEUROSCI.0659-17.2017
– volume: 42
  start-page: 241
  year: 2001
  ident: 868_CR42
  publication-title: J Child Psychol Psychiatry.
  doi: 10.1111/1469-7610.00715
– volume: 7
  start-page: 1
  year: 2016
  ident: 868_CR9
  publication-title: Front Psychiatry.
  doi: 10.3389/fpsyt.2016.00188
– volume: 99
  start-page: 743
  year: 2010
  ident: 868_CR78
  publication-title: Acta Paediatr Int J Paediatr.
  doi: 10.1111/j.1651-2227.2010.01755.x
– volume: 8
  start-page: 1
  year: 1980
  ident: 868_CR76
  publication-title: Ann Neurol.
  doi: 10.1002/ana.410080102
– volume: 67
  start-page: 3
  year: 1988
  ident: 868_CR47
  publication-title: Percept Mot Skills.
  doi: 10.2466/pms.1988.67.1.3
– volume: 67
  start-page: 307
  year: 1986
  ident: 868_CR62
  publication-title: Neurosci Lett.
  doi: 10.1016/0304-3940(86)90327-7
– volume: 60
  start-page: 524
  year: 2003
  ident: 868_CR2
  publication-title: Arch Gen Psychiatry.
  doi: 10.1001/archpsyc.60.5.524
– volume: 255
  start-page: 255
  year: 2012
  ident: 868_CR63
  publication-title: Science.
– volume: 62
  start-page: 774
  year: 2012
  ident: 868_CR49
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2012.01.021
– volume: 194
  start-page: 230
  year: 2011
  ident: 868_CR29
  publication-title: Psychiatry Res.
  doi: 10.1016/j.pscychresns.2011.04.007
– ident: 868_CR1
  doi: 10.1176/appi.books.9780890425596
– volume: 16
  year: 2018
  ident: 868_CR85
  publication-title: BMC Med.
  doi: 10.1186/s12916-017-0993-3
– volume: 344
  start-page: 1357
  year: 2014
  ident: 868_CR65
  publication-title: Science
  doi: 10.1126/science.1243091
– volume: 45
  start-page: 287
  year: 1999
  ident: 868_CR26
  publication-title: Ann Neurol.
  doi: 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9
– volume: 28
  start-page: 2398
  year: 2014
  ident: 868_CR79
  publication-title: FASEB J.
  doi: 10.1096/fj.13-246546
– volume: 560
  start-page: 589
  year: 2018
  ident: 868_CR68
  publication-title: Nature.
  doi: 10.1038/s41586-018-0416-4
– volume: 74
  start-page: 765
  year: 2004
  ident: 868_CR54
  publication-title: Am J Hum Genet.
  doi: 10.1086/383251
– volume: 28
  start-page: 20
  year: 2018
  ident: 868_CR7
  publication-title: JAMA.
– volume: 38
  start-page: 1083
  year: 1999
  ident: 868_CR14
  publication-title: Neuropharmacology.
  doi: 10.1016/S0028-3908(99)00010-6
– volume: 68
  start-page: 243
  year: 2017
  ident: 868_CR64
  publication-title: Annu Rev Psychol.
  doi: 10.1146/annurev-psych-010416-044046
– volume: 33
  start-page: 353
  year: 2008
  ident: 868_CR74
  publication-title: Neuropsychopharmacology.
  doi: 10.1038/sj.npp.1301406
– volume: 58
  start-page: 315
  year: 1961
  ident: 868_CR11
  publication-title: J Pediatr.
  doi: 10.1016/S0022-3476(61)80261-8
– volume: 159
  start-page: 107477
  year: 2019
  ident: 868_CR81
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2018.12.024
– volume: 109
  start-page: 5469
  year: 2012
  ident: 868_CR17
  publication-title: Proc Natl Acad Sci USA.
  doi: 10.1073/pnas.1112345109
– volume: 317
  start-page: 1553
  year: 2017
  ident: 868_CR86
  publication-title: JAMA.
  doi: 10.1001/jama.2017.3413
– volume: 31
  start-page: 968
  year: 2006
  ident: 868_CR50
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2006.01.021
– volume: 23
  start-page: 287
  year: 2005
  ident: 868_CR83
  publication-title: Int J Dev Neurosci.
  doi: 10.1016/j.ijdevneu.2004.05.004
– volume: 321
  start-page: 24
  year: 2016
  ident: 868_CR19
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2015.11.010
– volume: 6
  start-page: 571
  year: 2013
  ident: 868_CR24
  publication-title: Autism Res.
  doi: 10.1002/aur.1317
– volume: 61
  start-page: 440
  year: 2007
  ident: 868_CR60
  publication-title: Synapse.
  doi: 10.1002/syn.20382
– volume: 7
  start-page: 586
  year: 2002
  ident: 868_CR45
  publication-title: J Int Neuropsychol Soc.
– ident: 868_CR38
– volume: 10
  start-page: eaam8434
  year: 2018
  ident: 868_CR41
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aam8434
– volume: 263
  start-page: 256
  year: 2006
  ident: 868_CR37
  publication-title: Synapse.
  doi: 10.1002/syn.20297
– volume: 69
  start-page: 1003
  year: 2012
  ident: 868_CR72
  publication-title: Arch Gen Psychiatry.
– volume: 19
  start-page: 397
  year: 1989
  ident: 868_CR73
  publication-title: J Autism Dev Disord.
  doi: 10.1007/BF02212938
– volume: 342
  start-page: 212
  year: 2017
  ident: 868_CR56
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2016.02.037
– volume: 277
  start-page: 3
  year: 2015
  ident: 868_CR59
  publication-title: Behav Brain Res.
  doi: 10.1016/j.bbr.2014.05.022
– volume: 207
  start-page: 149
  year: 2015
  ident: 868_CR67
  publication-title: Br J Psychiatry.
  doi: 10.1192/bjp.bp.113.143784
– volume: 60
  start-page: 47
  year: 2002
  ident: 868_CR89
  publication-title: Neuroimage.
  doi: 10.1006/nimg.2002.1152
– volume: 36
  start-page: 623
  year: 2006
  ident: 868_CR43
  publication-title: J Autism Dev Disord.
  doi: 10.1007/s10803-006-0107-0
– volume: 1189
  start-page: 203
  year: 2008
  ident: 868_CR57
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2007.10.063
– volume: 235
  start-page: 1317
  year: 2018
  ident: 868_CR88
  publication-title: Psychopharmacology.
  doi: 10.1007/s00213-018-4872-1
– volume: 43
  start-page: 678
  year: 2002
  ident: 868_CR34
  publication-title: J Nucl Med.
– volume: 61
  start-page: 724
  year: 2007
  ident: 868_CR61
  publication-title: Synapse.
  doi: 10.1002/syn.20422
– volume: 4
  start-page: 153
  year: 1996
  ident: 868_CR51
  publication-title: Neuroimage.
  doi: 10.1006/nimg.1996.0066
– volume: 23
  start-page: 75
  year: 2005
  ident: 868_CR22
  publication-title: Int J Dev Neurosci.
  doi: 10.1016/j.ijdevneu.2004.07.022
– volume: 23
  start-page: 171
  year: 2005
  ident: 868_CR27
  publication-title: Int J Dev Neurosci.
  doi: 10.1016/j.ijdevneu.2004.08.002
– volume: 39
  start-page: 1408
  year: 2008
  ident: 868_CR39
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2007.10.016
– volume: 56
  start-page: 479
  year: 2001
  ident: 868_CR21
  publication-title: Brain Res Bull.
  doi: 10.1016/S0361-9230(01)00615-3
– volume: 42
  start-page: 427
  year: 2017
  ident: 868_CR77
  publication-title: Neuropsychopharmacology.
  doi: 10.1038/npp.2016.166
– volume: 22
  start-page: 490
  year: 2002
  ident: 868_CR36
  publication-title: J Cereb Blood Flow Metab.
  doi: 10.1097/00004647-200204000-00013
– volume: 197
  start-page: 1
  year: 2011
  ident: 868_CR20
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2011.10.005
– volume: 10
  start-page: 821
  year: 2017
  ident: 868_CR70
  publication-title: Autism Res.
  doi: 10.1002/aur.1761
– volume: 43
  start-page: 491
  year: 2004
  ident: 868_CR13
  publication-title: J Am Acad Child Adolesc Psychiatry.
  doi: 10.1097/00004583-200404000-00016
– volume: 36
  start-page: 6041
  year: 2016
  ident: 868_CR80
  publication-title: J Neurosci.
  doi: 10.1523/JNEUROSCI.2534-15.2016
– volume: 24
  start-page: 919
  year: 2014
  ident: 868_CR12
  publication-title: Eur Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2014.02.004
– volume: 74
  start-page: 880
  year: 2010
  ident: 868_CR55
  publication-title: Med Hypotheses.
  doi: 10.1016/j.mehy.2009.11.015
– volume: 50
  start-page: 593
  year: 2008
  ident: 868_CR32
  publication-title: Dev Med Child Neurol.
  doi: 10.1111/j.1469-8749.2008.03027.x
– volume: 60
  start-page: 1347
  year: 2011
  ident: 868_CR23
  publication-title: Neuropharmacology.
  doi: 10.1016/j.neuropharm.2011.02.002
– volume: 57
  start-page: 289
  year: 2007
  ident: 868_CR82
  publication-title: Neurosci Res.
  doi: 10.1016/j.neures.2006.10.018
– volume: 501
  start-page: 179
  year: 2013
  ident: 868_CR69
  publication-title: Nature.
  doi: 10.1038/nature12518
– volume: 2
  start-page: 268
  year: 1990
  ident: 868_CR75
  publication-title: J Neuropsychiatry Clin Neurosci.
  doi: 10.1176/jnp.2.3.268
– volume: 5
  start-page: 357
  year: 1969
  ident: 868_CR16
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(69)90113-7
– volume: 60
  start-page: 355
  year: 2009
  ident: 868_CR15
  publication-title: Annu Rev Med.
  doi: 10.1146/annurev.med.60.042307.110802
– volume: 30
  start-page: 622
  year: 2000
  ident: 868_CR44
  publication-title: J Autism Dev Disord.
  doi: 10.1023/A:1005608014889
– volume: 45
  start-page: 672
  year: 2004
  ident: 868_CR66
  publication-title: J Child Psychol Psychiatry Allied Discip.
  doi: 10.1111/j.1469-7610.2004.00262.x
– volume: 69
  start-page: 46
  year: 2012
  ident: 868_CR3
  publication-title: Arch Gen Psychiatry.
  doi: 10.1001/archgenpsychiatry.2011.144
– volume: 56
  start-page: 702
  year: 2015
  ident: 868_CR10
  publication-title: J Child Psychol Psychiatry Allied Discip.
  doi: 10.1111/jcpp.12329
– volume: 24
  start-page: 191
  year: 2012
  ident: 868_CR30
  publication-title: J Neuropsychiatry Clin Neurosci.
  doi: 10.1176/appi.neuropsych.11080202
– volume: 61
  start-page: 882
  year: 2007
  ident: 868_CR35
  publication-title: Synapse.
  doi: 10.1002/syn.20443
– volume: 57
  start-page: 289
  year: 1995
  ident: 868_CR52
  publication-title: J R Stat Soc Ser B.
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 87
  start-page: 52
  year: 2001
  ident: 868_CR53
  publication-title: Heredity.
  doi: 10.1046/j.1365-2540.2001.00901.x
– volume: 151
  start-page: 642
  year: 2019
  ident: 868_CR25
  publication-title: J Neurochem.
  doi: 10.1111/jnc.14832
– volume: 67
  start-page: 59
  year: 2010
  ident: 868_CR33
  publication-title: Arch Gen Psychiatry.
  doi: 10.1001/archgenpsychiatry.2009.137
– ident: 868_CR87
  doi: 10.1002/14651858.CD004677.pub3
– volume: 163
  start-page: 934
  year: 2006
  ident: 868_CR28
  publication-title: Am J Psychiatry.
  doi: 10.1176/ajp.2006.163.5.934
SSID ssj0014765
Score 2.496687
Snippet Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental...
SourceID swepub
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1647
SubjectTerms 59/78
631/378
692/699/476/1373
Adult
Autism
Autism Spectrum Disorder - diagnostic imaging
Autistic Disorder - diagnostic imaging
Behavioral Sciences
Biological Psychology
Brain - diagnostic imaging
Brain - metabolism
Brain stem
Carrier proteins
Cognitive ability
Health aspects
Humans
Hypotheses
Medicine
Medicine & Public Health
Neurodevelopment
Neurosciences
Pharmacotherapy
Phenotypes
Physiological aspects
Positron emission tomography
Psychiatry
Serotonin
Serotonin Plasma Membrane Transport Proteins - genetics
Serotonin Plasma Membrane Transport Proteins - metabolism
Serotonin transporter
Substantia grisea
Tomography
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB5BERIXxD-BgoyE4ABRk9iJ7ROqEFWFBCcq7c1yHEdUtEnZpEi98RA8IU_CjONNyR72Fu04idczHs9fvgF47du20crnqP08T4USbaosR0Muk8huWxdVgNj48rU6PhGfV-UqBtyGWFa50YlBUTe9oxj5QUFlkHhca_nh4mdKXaMouxpbaNyEWwRdRiVdcjU7XLmQoZVkzkvKdioRP5rJuDoYUHmrLCXniax6lfLFwbStnv87n7ZrJ-cE6hbYaDigju7B3WhZssNJFO7DDd89gNtTr8mrh2BQK_QjBV_ZOAOar5n9ZU_PJqzuK4a0gMcxMArPMotCOZz__f3HslDbte47Ru3hKMDGxv48ol2zAFH7CE6OPn37eJzG7gqpK6UeU_TLKs59rVuX59bzVlj0nkoCtOPIV-F8ZivNLXe1075yrVKV0F67Vpe6QMpj2Ov6zj8F5lWhG3TRs7IuhFSNznjRFF4SOFjjhEog3yytcRF6nDpgnJmQAufKTOwwyA4T2GF4Au_mey4m4I2do98SxwztSnyys_HjApwf4VuZQzSsRLB-E9hfjMRVc0vyhucm7ubBXMteAq9mMt1JFWqd7y9xjOCUws2rMoEnk4jM8-ZoA6ClJRKQC-GZBxDG95LSnX4PWN8KzU3J8b3vN2J2Pa1dy_FmEsXFG-JPP_DKG1ERsuGz3X_3OdwpqIYnFHjuw964vvQv0Agb65dhp_0DmL8u4g
  priority: 102
  providerName: ProQuest
Title Serotonin transporter availability in adults with autism—a positron emission tomography study
URI https://link.springer.com/article/10.1038/s41380-020-00868-3
https://www.ncbi.nlm.nih.gov/pubmed/32848204
https://www.proquest.com/docview/2533050597
https://www.proquest.com/docview/2437841165
https://pubmed.ncbi.nlm.nih.gov/PMC8159737
http://kipublications.ki.se/Default.aspx?queryparsed=id:144502071
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9QwEB_uD8q9iJ5_rnouEUQftNg2aZs87i63HMItIh7sW0jTlDu868puT7g3P4Sf0E_iTNqtdpEDn7bspGnITJJfMpPfALx2VVUq6WKc_RwPhRRVKA1HIBflqG5TJJmn2DibZ6fn4uMiXexAsrkL44P2PaWln6Y30WEf1jjZyiikzQ6hcBnyXdgn6nay6mk27T0HIvfpI2OekodTiu6iTMTlP-oYLEbbU_Jfa9J2vGTvNN0iGPWL0uwhPOjQJBu37X8EO64-hHttfsnbQ7h_1nnOH4PGSWHZ0Nkra3o-8xUz383lVUvVfctQ5uk41oxOZ5lBm1xf__rx0zAf2rVa1oyyw9H5GmuW1x3ZNfMMtU_gfHbyZXoadskVQpvmqglxW5Zx7gpV2Tg2jlfC4OYpJT47jmoV1kUmU9xwW1jlMltJmQnllK1UqhKUPIW9elm7I2BOJqrEHXqUFonIZakinpSJy4kbrLRCBhBvelnbjnmcEmBcae8B51K3mtGoGe01o3kA7_p3vrW8G3eWfkvK0zQosWZrursF2D6it9JjxFXCg98AjgclsdfsULxRv-4G81onFIGLSFHlAbzqxfQmBajVbnmDZQQnD26cpQE8a62lbzdHCIBASwSQD-yoL0AU30NJfXnhqb4los2c43ffbyzuT7Pu6o43rVUOvtD99RWfnBYZERs-_796X8BBQiE9Pt7zGPaa1Y17iZisKUawmy_yEeyPZ5PJHH8nJ_NPn0d-aP4GDYgz1A
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqrRBcEG9SChiJxwGiJraT2AeECrTa0naFUCv1ZhLHEVXbpOymoL3xI_gd_Ch-CTPOo2QPe-stip3E8Yzn4Rl_Q8hzWxS5kjYE6We5L6QofJlyMOSCBMidZix2EBv7k3h8KD4dRUcr5E93FgbTKjuZ6AR1XhncI99gmAYJ6lol786_-1g1CqOrXQmNhi127fwnuGyztzsfgb4vGNveOvgw9tuqAr6JElX74I_EnNtMFSYMU8sLkYLXECGQG4f_EcYGaax4yk1mlI1NIWUslFWmUJFiMYIvgchfFRxcmRFZfb81-fylj1uIxBWvDHmE8VUp2mM6AZcbM1AXMvDRXUM_Qvp8oAoXFcJ_GnExW7MP2S7AmzqVuH2L3GxtWbrZMN9tsmLLO-RaU91yfpdokENVjdu9tO4h1Kc0_ZEenzbo4HMKbQ4BZEZxQ5imsAxmZ39__U6pyyabViXFgnS4pUfr6qzF16YOFPceObySmb9PRmVV2oeEWslUbjMWRBkTicxVwFnObIJwZLkR0iNhN7XatGDnWHPjVLugO5e6IYcGcmhHDs098rp_5ryB-lja-xVSTKMcgDebtD3OAONDRC29CaaccPa2R9YHPWHWzLC5o7lu5cdMX3K7R571zfgk5sSVtrqAPoJj0DiMI488aFikHzcHqwNsO-GRZMA8fQdEFR-2lMffHLq4BAM34fDdNx2bXQ5r2XS8bFhx8IX21glcWS1ixFJcW_67T8n18cH-nt7bmew-IjcYZhC59NJ1MqqnF_YxmIB19qRdd5R8veql_g9lN21R
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIhAXxJtAASPxOEC0ie0k9gGhirJqKVQcqLQ34ziOqGiTspuC9saP4Nfwc_glzDiPkj3srbcodhLHM56HZ_wNIU9dWRZKuhikn-OhkKIMpeFgyEUZkNvkLPUQGx8P0t1D8X6WzDbIn_4sDKZV9jLRC-qitrhHPmGYBgnqWmWTskuL-LQzfXP6PcQKUhhp7ctptCyy75Y_wX1bvN7bAVo_Y2z67vPb3bCrMBDaJFNNCL5JyrnLVWnj2DheCgMeRIKgbhz-TVgXmVRxw21ulUttKWUqlFO2VIliKQIxgfi_lPEkxjWWzQZnLxaZL2MZ8wQjrVJ0B3YiLicLUBwyCtFxQ49ChnykFFdVw3-6cTVvcwjergCdeuU4vU6udVYt3W7Z8AbZcNVNcrmtc7m8RTRIpLrBjV_aDGDqc2p-mKPjFid8SaHNY4EsKG4NUwMLYnHy99dvQ31e2byuKJamw8092tQnHdI29fC4t8nhhcz7HbJZ1ZW7R6iTTBUuZ1GSM5HJQkWcFcxlCExWWCEDEvdTq20He47VN461D79zqVtyaCCH9uTQPCAvh2dOW9CPtb1fIMU0SgR4szXdwQYYH2Jr6W0w6oS3vAOyNeoJs2bHzT3NdSdJFvqc7wPyZGjGJzE7rnL1GfQRHMPHcZoE5G7LIsO4OdgfYOWJgGQj5hk6IL74uKU6-upxxiWYuhmH777q2ex8WOum43nLiqMvdLe-wZXTIkVUxfvrf_cxuQILXH_YO9h_QK4yTCXyeaZbZLOZn7mHYAs2-SO_6Cj5ctGr_B9T6nAh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serotonin+transporter+availability+in+adults+with+autism-a+positron+emission+tomography+study&rft.jtitle=Molecular+psychiatry&rft.au=Andersson%2C+Max&rft.au=Tangen%2C+%C3%84mma&rft.au=Farde%2C+Lars&rft.au=B%C3%B6lte%2C+Sven&rft.date=2021-05-01&rft.issn=1476-5578&rft.eissn=1476-5578&rft.volume=26&rft.issue=5&rft.spage=1647&rft_id=info:doi/10.1038%2Fs41380-020-00868-3&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon